- Notification that Quarterly Report will be submitted late (NT 10-Q)
15 November 2010 - 10:41PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
Commission
File Number: 000-51497
(Check
One):
¨
Form 10-K
¨
Form
20-F
¨
Form 11-K
x
Form
10-Q
¨
Form N-SAR
For
Period Ended: September 30, 2010
¨
Transition Report on
Form 10-K
¨
Transition Report on
Form 20-F
¨
Transition Report on
Form 11-K
¨
Transition Report on
Form 10-Q
¨
Transition Report on
Form N-SAR
For the
Transition Period Ended: N/A
Read
attached instruction sheet before preparing form. Please print or
type.
Nothing
in this form shall be construed to imply that the Commission has verified any
information contained herein.
If the
notification relates to a portion of the filing checked above, identify the
item(s) to which the notification relates: N/A
PART
I — REGISTRANT INFORMATION
Full Name
of Registrant: BIO-BRIDGE SCIENCE, INC.
Former
Name if Applicable:
Address
of Principal Executive Office
(Street
and number): 1801 South Meyers Road, Suite 220
City,
State and Zip Code: Oakbrook Terrace, Illinois, 60181
PART
II — RULES 12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate.)
|
(a)
|
The
reasons described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or expense;
|
|
|
|
x
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K,
Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or
before the fifteenth calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form 10-Q, or portion
thereof will be filed on or before the fifth calendar day following the
prescribed due date; and
|
|
|
|
|
(c)
|
The
accountant's statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable. The accountant's statement has bee attached
as an exhibit to this
Notification.
|
PART
III – NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR,
or the transition report portion thereof, could not be filed within
the prescribed time
period. (Attach extra sheets if needed.)
Management
of Bio-Bridge Science Inc., a Delaware corporation (the "Company"), deems
additional time is necessary in order for the Company's auditors to complete
their review of its Quarterly Report on Form 10-Q for the period ended September
30, 2010. Management deems it necessary that additional time be
provided in order to ensure all material information is made in its Quarterly
Report. Management anticipates that complete, thorough and accurate disclosure
of the filing of its Quarterly Report within the extension period
provided.
PART
IV — OTHER INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
Dr.
Liang Qiao
|
|
630-613-9687
|
(Name)
|
|
(Area
Code) (Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed? If the
answer is no, identify report(s).
x
Yes
¨
No
|
(3)
|
Is
it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
¨
Yes
x
No
|
If so,
attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why are reasonable
estimate of the results cannot be made.
BIO-BRIDGE
SCIENCE, INC.
(Name of
Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto
duly authorized.
Date:
November 15, 2010
|
By:
|
/s/
Dr. Liang Qiao
|
|
|
Dr.
Liang Qiao
|
|
|
Chief
Executive Officer
|
|
|
Principal
Executive Officer
|
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
Von Jul 2023 bis Jul 2024